The Centers for Disease Control and Prevention (CDC) issued updated guidance on the use of JYNNEOS and ACAM2000 vaccines in the context of a public health emergency (PHE). These considerations include using an alternate regimen including intradermal administration and a smaller injection volume of the JYNNEOS vaccine under an Emergency Use Authorization (EUA). Read the full Interim Clinical Considerations.
